🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03815U300 (prev. 03815U102 )
- Market Cap
- Micro Cap
- Previous Symbol
- APDN (changed 11/10/2014)
- Previous Name
- Applied DNA Sciences, Inc.
Business: BNB Plus Corp.is a biotechnology company executing a yield focused BNB digital asset treasury strategy, while also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets. The Company delivers non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated strategy blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space. The Company continues to commercialize proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Notes: October 31, 2019 -- Applied DNA Sciences, Inc. (NASDAQ: APDN) , a leader in polymerase chain reaction (PCR)-based DNA manufacturing for product authenticity and traceability solutions, announced today that it will effect a 1-for-40 reverse split of its outstanding common stock effective at 12:01 AM Eastern Time on Friday, November 1, 2019. The Company’s common stock will begin trading on a split-adjusted basis when The Nasdaq Capital Market opens on Friday, November 1, 2019 under the existing symbol “APDN.” Applied DNA’s common stock will trade under a new CUSIP number, #03815U300.
Company Contact
- CEO
- Clay Shorrock
- CFO
- Beth Jantzen
- Headquarters
- 50 Health Sciences Drive, Stony Brook, NY 11790,
- Phone
- 631-240-8800
- Fax
- 631-240-8900
- Investor Relations
- Sanjay M. Hurry · 917-733-5573 · sanjay.hurry@adnas.com